Intelligent Bio Solutions Inc. (INBS) is priced at $1.18 after the most recent trading session. At the very opening of the session, the stock price was $0.2708 and reached a high price of $0.2754, prior to closing the session it reached the value of $0.26. The stock touched a low price of $0.25.Recently in News on January 23, 2023, Intelligent Bio Solutions Reaches Key Milestone in Biosensor Platform Development. Achieves Record 4x Improvement in Time-To-Result to Provide Test Results in Under 1 Minute. You can read further details here
Intelligent Bio Solutions Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.6000 on 01/23/23, with the lowest value was $0.1800 for the same time period, recorded on 01/03/23.
Intelligent Bio Solutions Inc. (INBS) full year performance was -83.63%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Intelligent Bio Solutions Inc. shares are logging -23.05% during the 52-week period from high price, and 597.06% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.17 and $1.54.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 98928410 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Intelligent Bio Solutions Inc. (INBS) recorded performance in the market was 31.07%, having the revenues showcasing -43.52% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 4.60M, as it employees total of 12 workers.
Specialists analysis on Intelligent Bio Solutions Inc. (INBS)
During the last month, 0 analysts gave the Intelligent Bio Solutions Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.4075, with a change in the price was noted +0.62. In a similar fashion, Intelligent Bio Solutions Inc. posted a movement of +90.63% for the period of last 100 days, recording 938,832 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for INBS is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Trends and Technical analysis: Intelligent Bio Solutions Inc. (INBS)
Raw Stochastic average of Intelligent Bio Solutions Inc. in the period of last 50 days is set at 78.72%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 78.72%. In the last 20 days, the company’s Stochastic %K was 62.12% and its Stochastic %D was recorded 52.95%.
Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 31.07%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -65.74%, alongside a downfall of -83.63% for the period of the last 12 months. The shares increased approximately by -6.39% in the 7-day charts and went up by -20.34% in the period of the last 30 days. Common stock shares were lifted by -43.52% during last recorded quarter.